|
COVID-19 Vaccination In The Philippines
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government. The Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of September 20, 2022, 165,005,000 total vaccine doses have been administered throughout the country, with 72,932,489 being fully vaccinated, 18,989,775 1st booster doses and 2,703,838 2nd booster doses administered. Background and timeline The ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Resbakuna Logo
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government. The Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of September 20, 2022, 165,005,000 total vaccine doses have been administered throughout the country, with 72,932,489 being fully vaccinated, 18,989,775 1st booster doses and 2,703,838 2nd booster doses administered. Background and timeline The ''C ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Pfizer–BioNTech COVID-19 Vaccine
The Pfizer–BioNTech COVID-19 vaccine ( INN: tozinameran), sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in people aged five years and older in some jurisdictions, twelve years and older in some jurisdictions, and for people sixteen years and older in other jurisdictions, to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months i ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Czar (political Term)
Czar, sometimes spelled tsar, is an informal title used for certain high-level officials in the United States and United Kingdom, typically granted broad power to address a particular issue. In the United States, czars are generally executive branch officials appointed by the head of the executive branch (such as the president for the federal government, or the governor of a state). Some czars may require confirmation with Senate approval or not. Some appointees outside the executive branch are called czars as well. Specific instances of the term are often a media creation. In the United Kingdom, the term is more loosely used to refer to high-profile appointments who devote their skills to one particular area. United States Development of term The word ''czar'' is of Slavic origin, etymologically originating from the name ''Caesar'', as with the word ''tsar'', a title of sovereignty, first created and used by the First Bulgarian Empire. The title was later adopted and used by ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Carlito Galvez Jr
Carlito means "little Carlos". It may refer to: Biology * ''Carlito'' (genus), a genus of tarsiers *The Philippine tarsier (''Carlito syrichta''), the only extant species in the above genus People * Carlito (name) * Carlito (wrestler), a ring name used by professional wrestler, Carlos Edwin Colón Jr. Other * Carlito (typeface), a typeface released by Google with metrics compatible with Microsoft's Calibri typeface See also * Carlitos *Carloto Carloto is a name. Notable people with this name include the following: Given name *Carloto Cotta (born 1984), Portuguese actor Surname * Eduardo Luís Carloto (born 1981), Brazilian footballer See also * Carl Otto * Carlito (other) *C ... * Thiago Carleto {{disambiguation ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Inter-Agency Task Force For The Management Of Emerging Infectious Diseases
The Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) is a task force organized by the executive of the government of the Philippines to respond to affairs concerning emerging infectious diseases in the country. History The IATF-EID was created through Executive Order No. 168 issued by President Benigno Aquino III in 2014. It was organized as the government's instrument to assess, monitor, contain, control and prevent the spread of any potential epidemic in the Philippines. COVID-19 pandemic The IATF-EID convened in January 2020 to address the growing viral outbreak in Wuhan, China. They made a resolution to manage the spreading of the new virus, which was known at the time as 2019 novel coronavirus (2019-nCoV) and eventually renamed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. On March 9, 2020, President Duterte called the IATF-EID amidst the rising cases of COVID-19 in the Philippines ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
President Rodrigo Roa Duterte Holds A Meeting With Members Of The Inter-Agency Task Force On The Emerging Infectious Diseases (IATF-EID) At The Matina Enclaves In Davao City On June 4, 2020 10
President most commonly refers to: *President (corporate title) *President (education), a leader of a college or university *President (government title) President may also refer to: Automobiles * Nissan President, a 1966–2010 Japanese full-size sedan * Studebaker President, a 1926–1942 American full-size sedan * VinFast President, a 2020–present Vietnamese mid-size SUV Film and television *'' Præsidenten'', a 1919 Danish silent film directed by Carl Theodor Dreyer * ''The President'' (1928 film), a German silent drama * ''President'' (1937 film), an Indian film * ''The President'' (1961 film) * ''The Presidents'' (film), a 2005 documentary * ''The President'' (2014 film) * ''The President'' (South Korean TV series), a 2010 South Korean television series * ''The President'' (Palestinian TV series), a 2013 Palestinian reality television show *''The President Show'', a 2017 Comedy Central political satirical parody sitcom Music *The Presidents (American soul band) *The ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Novavax COVID-19 Vaccine
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). Full results from Nuvaxovid's pivotal phase III trial were published in December 2021. Medical uses The Novavax COVID19 vaccine is indicated for active immunization to prevent COVID19 caused by SARS-CoV-2. Efficacy A vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the 95% confidence interval. Efficacy is closely related to effectiveness, which is generally expected to slowly decrease over time. In December 2021, Novavax reported, that its phase III trial showed the vaccine achieved its primary endpoint of preventing infection at least seven days after the second dose. Overall efficacy against different SARS-CoV-2s was 90.4% and efficacy against moderate-to-severe disease was 100%. Trials were conducted before the eme ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Sputnik Light
Sputnik Light (russian: Спутник Лайт, Sputnik Layt or Lajt) is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of . The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly. It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier. Effectiveness A vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the 95% confidence interval. As of September 2021, no study on Sputnik Light reported confidence intervals, so it is not possible to know the accuracy of the estimates. Effectiveness is generally expected to slowly decrease over time. A real-world study with participants aged 60–79 years in Ar ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Sinopharm BIBP COVID-19 Vaccine
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, resulting in the two different acronyms BBIBP and BIBP for the same vaccine). It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine (Vero Cell), not to be confused with the similar product name of CoronaVac. Peer-reviewed results published in ''JAMA'' of Phase III trials in United Arab Emirates and Bahrain showed that the vaccine is 78.1% effective against symptomatic cases and 100% against severe cases (21 cases in vaccinated group vs. 95 c ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Moderna COVID-19 Vaccine
The Moderna COVID19 vaccine (INN: elasomeran), sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in people aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart. It is an mRNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. It is authorized for use at some level in many countries. In August and September 2022, bivalent versions of the vaccine (Moderna COVID-19 Vaccine, Bivalent) containing elasome ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Covaxin
Covaxin (codenamed as BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology. As of October 2021, 110.6 million people in India have received Covaxin. On 3 November 2021, the World Health Organization (WHO) validated the vaccine for emergency use. As of 31 January 2022, Covaxin has been granted emergency use approval in 13 countries Medical uses Effectiveness A vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the 95% confidence interval. Effectiveness is generally expected to slowly decrease over time. Efficacy A phase 3 clinical trial with 25,798 participants found that the vaccine is effective against asymptomatic cases, effective against symptomatic disease, effective against severe disease, and effective against the Delta variant. Manufacturing As an inactivated vaccine, Covaxin uses a m ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Janssen COVID-19 Vaccine
The Janssen COVID19 vaccine, sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID19. The body's immune system responds to this spike protein to produce antibodies. The vaccine requires only one dose and does not need to be stored frozen. Clinical trials for the vaccine were started in June 2020, with phaseIII involving around 43,000 people. On 29 January 2021, Janssen announced that 28 days after a completed vaccination, the vaccine was 66% effective in a one-dose regimen in preventing symptomatic COVID19, with an 85% efficacy in preventing severe COVID19 and 100% efficacy in preventing hospitalization or death caused by the disease ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
_E.jpg "Click for more on -> Pfizer–BioNTech COVID-19 Vaccine")
